Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Randomized controlled trial of interferon A 5mU daily plus ribavirin 1000mg daily versus interferon A 3mU tiw plus ribavirin 1000mg daily in patients with HCV who have never received previous therapy

Randomized controlled trial of interferon A 5mU daily plus ribavirin 1000mg daily versus interferon A 3mU tiw plus ribavirin 1000mg daily in patients with HCV who have never received previous therapy. Hepatology. 2000; (32):363A.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.